The CAT evaluates and brings new technologies top campus that are available to all UCSF labs and provides guidance for projects. Over the past decade, the CAT has been a hub for Next Generation Sequencing (NGS) at UCSF and beyond, supporting the development of NGS-based non-invasive pre-natal testing and pathogen diagnostics. Dr. Chow also runs a research program to devise new applications for NGS and to develop rapid pathogen detection systems in resource poor settings. He received his BA from the University of California, Berkeley, and his PhD performing genomic research in Tuberculosis at UCSF.